Literature DB >> 7922249

Epidemiology of microalbuminuria in diabetes and in the background population.

C E Mogensen1, P L Poulsen.   

Abstract

Microalbuminuria is defined in principle as abnormally increased albumin excretion below the level that is characteristic for proteinuria. In diabetes, microalbuminuria is defined as having an excretion rate of 20 to 200 micrograms/min. This level of albuminuria predicts overt renal disease in both non-insulin-dependent diabetes mellitus and insulin-dependent diabetes mellitus patients, and it is also associated with increased mortality. In nondiabetic individuals, the albumin excretion rate is not normally distributed with a skewed upper distribution. Excretion rate is lower during daytime, even during rest, than overnight. The median values in several studies for daytime and overnight albumin excretion rates are approximately 4 and 3 micrograms/min, respectively, with the upper 90th percentile approximately 15 and 10 micrograms/min, respectively. Microalbuminuria in population studies is significantly, but weakly, correlated to blood pressure, triglycerides, and low high-density lipoprotein cholesterol, as well as plasma glucose and obesity. These parameters are elements of the so-called metabolic syndrome. New studies in insulin-dependent diabetes mellitus on the transition from normo- to microalbuminuria show that high normal excretion rate and poor metabolic control are associated with progression. In non-insulin-dependent diabetes mellitus, microalbuminuria is quite common (20% to 25% of patients) in both newly diagnosed patients and patients with established diabetes. In many studies, a prevalence of approximately 20% is found, and again microalbuminuria is associated with components of the metabolic syndrome, which includes poor metabolic control and blood pressure elevation.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1994        PMID: 7922249     DOI: 10.1097/00041552-199405000-00004

Source DB:  PubMed          Journal:  Curr Opin Nephrol Hypertens        ISSN: 1062-4821            Impact factor:   2.894


  5 in total

Review 1.  New pharmacological treatments for improving renal outcomes in diabetes.

Authors:  Anne-Emilie Declèves; Kumar Sharma
Journal:  Nat Rev Nephrol       Date:  2010-05-04       Impact factor: 28.314

2.  Albuminuria is a marker of increasing intracranial and extracranial vascular involvement in Type 2 diabetic Chinese patients.

Authors:  G N Thomas; J W Lin; W W M Lam; B Tomlinson; V Yeung; J C N Chan; K S Wong
Journal:  Diabetologia       Date:  2004-08-25       Impact factor: 10.122

3.  A novel indicator of widespread endothelial damage and ischemia in diabetic patients: ischemia-modified albumin.

Authors:  Kubilay Ukinc; Selcuk Eminagaoglu; Halil Onder Ersoz; Cihangir Erem; Caner Karahan; Arif Bayram Hacihasanoglu; Mustafa Kocak
Journal:  Endocrine       Date:  2009-09-26       Impact factor: 3.633

Review 4.  What is the mechanism of microalbuminuria in diabetes: a role for the glomerular endothelium?

Authors:  S C Satchell; J E Tooke
Journal:  Diabetologia       Date:  2008-03-18       Impact factor: 10.122

Review 5.  Renal Effects of DPP-4 Inhibitors: A Focus on Microalbuminuria.

Authors:  Martin Haluzík; Jan Frolík; Ivan Rychlík
Journal:  Int J Endocrinol       Date:  2013-09-05       Impact factor: 3.257

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.